Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $457.00 | 31 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $290.41 | 10 | $0 (2022) |
| GENZYME CORPORATION | $33.60 | 2 | $0 (2017) |
| Allergan, Inc. | $25.98 | 2 | $0 (2021) |
| Alexion Pharmaceuticals, Inc. | $23.46 | 1 | $0 (2018) |
| EMD Serono, Inc. | $16.94 | 1 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $16.32 | 11 | $0 (2017) |
| Bayer HealthCare Pharmaceuticals Inc. | $14.25 | 1 | $0 (2017) |
| Eisai Inc. | $14.00 | 1 | $0 (2017) |
| US WorldMeds, LLC | $11.13 | 1 | $0 (2017) |
| Biogen, Inc. | $10.91 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $92.82 | 5 | Novartis Pharmaceuticals Corporation ($92.82) |
| 2021 | $35.23 | 2 | Novartis Pharmaceuticals Corporation ($20.78) |
| 2019 | $141.56 | 2 | Novartis Pharmaceuticals Corporation ($141.56) |
| 2018 | $58.99 | 3 | Alexion Pharmaceuticals, Inc. ($23.46) |
| 2017 | $128.40 | 19 | GENZYME CORPORATION ($33.60) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 2 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/21/2017 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 02/15/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.53 | General |
| Category: NEUROSCIENCE | ||||||
| 02/14/2017 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: NEUROSCIENCE | ||||||
| 01/26/2017 | Biogen, Inc. | TYSABRI (Biological), TECFIDERA | Food and Beverage | In-kind items and services | $10.91 | General |
| Category: NEUROLOGY | ||||||
| 01/12/2017 | Eisai Inc. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $14.00 | General |
| Category: Neurology | ||||||
| 01/04/2017 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 457 | 6,159 | $223,771 | $81,770 |
| 2022 | 8 | 454 | 5,853 | $207,653 | $80,687 |
| 2021 | 9 | 548 | 8,955 | $263,701 | $100,686 |
| 2020 | 10 | 534 | 6,015 | $196,535 | $74,437 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 12 | 5,700 | $100,434 | $27,319 | 27.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 136 | 136 | $44,200 | $21,223 | 48.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 103 | 103 | $26,265 | $11,912 | 45.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 80 | 89 | $13,706 | $7,270 | 53.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 43 | 48 | $10,752 | $6,088 | 56.6% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 15 | 15 | $10,950 | $3,119 | 28.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 28 | 28 | $4,508 | $2,021 | 44.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 28 | $2,744 | $1,810 | 66.0% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 12 | 12 | $10,212 | $1,008 | 9.9% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 15 | 5,400 | $95,148 | $26,468 | 27.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 123 | 123 | $39,975 | $19,932 | 49.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 127 | 127 | $32,385 | $14,431 | 44.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 81 | 90 | $13,860 | $8,324 | 60.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 33 | 36 | $8,064 | $4,509 | 55.9% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2022 | 14 | 14 | $10,220 | $2,963 | 29.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 27 | 29 | $4,669 | $2,190 | 46.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 34 | 34 | $3,332 | $1,868 | 56.1% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 17 | 8,399 | $147,990 | $40,790 | 27.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 137 | 137 | $44,525 | $22,449 | 50.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 106 | 106 | $27,030 | $12,792 | 47.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 121 | 138 | $21,252 | $11,125 | 52.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 45 | 47 | $10,528 | $6,241 | 59.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 77 | 78 | $7,644 | $4,616 | 60.4% |
| 95910 | Nerve transmission studies, 7-8 studies | Facility | 2021 | 11 | 11 | $1,573 | $940.72 | 59.8% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Facility | 2021 | 23 | 26 | $1,352 | $936.86 | 69.3% |
About Dr. Roy King, D.O
Dr. Roy King, D.O is a Neurology healthcare provider based in Asheville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861447443.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roy King, D.O has received a total of $457.00 in payments from pharmaceutical and medical device companies, with $92.82 received in 2022. These payments were reported across 31 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($457.00).
As a Medicare-enrolled provider, King has provided services to 1,993 Medicare beneficiaries, totaling 26,982 services with total Medicare billing of $337,579. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Asheville, NC
- Active Since 05/23/2006
- Last Updated 01/18/2022
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1861447443
Products in Payments
- KESIMPTA (Drug) $113.60
- AUBAGIO (Drug) $33.60
- SOLIRIS (Drug) $23.46
- MAYZENT (Drug) $20.46
- AIMOVIG (Biological) $18.59
- Rebif (Biological) $16.94
- GILENYA (Drug) $16.66
- APTIOM (Drug) $16.32
- BOTOX (Biological) $14.45
- Betaseron (Drug) $14.25
- Fycompa (Drug) $14.00
- VRAYLAR (Drug) $11.53
- APOKYN (Drug) $11.13
- TYSABRI (Biological) $10.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Asheville
James Patton, Md, MD
Neurology — Payments: $262,720
Robert Armstrong, Md, MD
Neurology — Payments: $142,313
Dr. Matthew Engelbrecht, M.d, M.D
Neurology — Payments: $51,456
Dr. Lei Lu
Neurology — Payments: $2,910
Alexander Schneider, M.d, M.D
Neurology — Payments: $1,133
Anna-Marieta Moise, M.d, M.D
Neurology — Payments: $1,118